U.S. drugmaker Pfizer Inc. (PFE) finalized a plan to develop a coronavirus vaccine in partnership with German drugmaker BioNTech SE (BNTX) with the target of jointly producing millions of vaccines by the end of 2020.Under the terms of the partnership, Pfizer will pay BioNTech $185 million upfront to develop the vaccine including an equity investment of about $113 million, with additional payments if certain milestones are achieved that could take its total investment to nearly $750 million, the two companies said in a joint statement.They plan to start clinical trials of the vaccine as early as the end of this …read more
Source:: Yahoo Finance
